TY - JOUR
T1 - Prophylactic treatment with monoclonal antibodies targeting the CGRP pathway for migraine prevention
AU - Oteri, Vittorio
AU - Douba, Zain
AU - Rayi, Appaji
AU - Letteri, Federica
AU - Moscote-Salazar, Luis Rafael
AU - Pacheco-Barrios, Kevin
AU - Celani, Maria Grazia
AU - Eusebi, Paolo
AU - Ricci, Stefano
AU - Sacco, Simona
AU - Cantisani, Teresa Anna
N1 - Publisher Copyright:
Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2023/7/5
Y1 - 2023/7/5
N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of monoclonal antibodies targeting the CGRP pathway compared with placebo or active treatments in preventing or reducing the symptoms of migraine attacks in adult and paediatric patients.
AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of monoclonal antibodies targeting the CGRP pathway compared with placebo or active treatments in preventing or reducing the symptoms of migraine attacks in adult and paediatric patients.
UR - http://www.scopus.com/inward/record.url?scp=85164206699&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD015505
DO - 10.1002/14651858.CD015505
M3 - Artículo
AN - SCOPUS:85164206699
SN - 1465-1858
VL - 2023
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 7
M1 - CD015505
ER -